Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TELA Bio, Inc. - Common stock
(NQ:
TELA
)
0.6749
+0.0199 (+3.04%)
Streaming Delayed Price
Updated: 10:14 AM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about TELA Bio, Inc. - Common stock
< Previous
1
2
3
4
5
6
Next >
TELA Bio Analysts Cut Their Forecasts After Q4 Results
↗
March 25, 2026
TELA Bio (NASDAQ:TELA) reported mixed Q4 results, with higher losses but lower sales than expected. Analysts lowered price targets for the stock.
Via
Benzinga
TELA Bio (TELA) Q4 2025 Earnings Call Transcript
↗
March 24, 2026
TELA Bio (TELA) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates
↗
March 24, 2026
Via
Chartmill
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results
March 24, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 23, 2026
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 18, 2025
Via
Benzinga
What's going on in today's after hours session
↗
November 17, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings
↗
November 14, 2025
Via
Benzinga
TELA Bio Inc (NASDAQ:TELA) Reports Mixed Q3 2025 Results, Misses Revenue Estimates
↗
November 13, 2025
TELA Bio reports Q3 2025 results with 9% revenue growth to $20.7M, missing estimates. The company improved its net loss and secured new financing for future expansion.
Via
Chartmill
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
November 13, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
November 13, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
Uncovering Potential: TELA Bio's Earnings Preview
↗
November 12, 2025
Via
Benzinga
TELA Bio to Announce Third Quarter 2025 Financial Results
November 04, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Appoints William Plovanic to Board of Directors
November 03, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
October 09, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 11, 2025
Via
Benzinga
TELA Bio Reports Second Quarter 2025 Financial Results
August 11, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 23, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2025 Financial Results
July 21, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 09, 2025
Via
Benzinga
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
